AqueSys Secures $35 million in Funding
AqueSys Inc. said Tuesday that secured $35 million in Series C financing. Longitude Capital and Rho Ventures led the round, with participation from existing investors Accuitive Medical Ventures, The Carlyle Group and SV Life Sciences. AqueSys is a medical device company that develops and makes implants for glaucoma.
29 June 2010•2 mins read
